An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.107 ↗Kurz gefasst
Fachartikel in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Anand Kumar Pandey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering Institute of Engineering and Technology Bundelkhand University Jhansi India. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology Engineering Institute of Engineering and Technology Bundelkhand University Jhansi India.
- Department of Biochemical Engineering and Biotechnology Indian Institute of Technology New Delhi India.
- NIMR-ICMR New Delhi India.
ORCID-Profile: Anand Kumar Pandey
Zitieren
APA
Pandey, A. K., & Verma, S. (2021). An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.107
Vancouver
Pandey AK, Verma S. An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.107
BibTeX
@article{Pandey2021,
author = {Pandey, Anand Kumar and Verma, Shalja},
title = {An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.107}
}
EUVIMED